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age, patients with early rehabilitation (n = 19) had 2.61 (SD 
2.96) exacerbations requiring systemic corticosteroids and/
or antibiotics, compared to 2.77 (SD 3.41) in patients with late 
rehabilitation (adjusted incidence rate ratio 0.83, 95% con-
fidence interval 0.43–1.63; p = 0.60). Over the 18-month 
period, patients with late rehabilitation experienced more 
dyspnea (difference on Chronic Respiratory Questionnaire 
dyspnea domain 0.74 and on the Medical Research Coun-
cil dyspnea scale 0.37), but neither these differences nor 
any difference in HRQOL domains reached statistical signifi-
cance.  Conclusions: We did not find any statistically signifi-
cant differences between early and late pulmonary rehabili-
tation. However, our trial indicates that early rehabilitation 
may lead to faster recovery of HRQOL after exacerbations 
compared to rehabilitation later on when patients are in a 
stable state. 
 
Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Pulmonary rehabilitation is an effective intervention 
for patients with chronic obstructive pulmonary disease 
(COPD) and is recommended by clinical guidelines  [1, 2] . 
 Key Words 
 Chronic obstructive pulmonary disease   Rehabilitation   
Exacerbation   Randomized trials   Quality of life 
 Abstract 
 Background:  Around the world, the timing of referral of 
chronic obstructive pulmonary disease (COPD) patients for 
pulmonary rehabilitation differs from immediately after ex-
acerbation (early) to later on when patients are in a stable 
state (late). There are no trials comparing the different time 
points of referral for pulmonary rehabilitation.  Objectives: 
Our aim was to compare the effects of early and late pulmo-
nary rehabilitation on exacerbation rates and health-related 
quality of life (HRQOL) in COPD patients with exacerbations. 
 Methods: We randomized COPD patients (Global Initiative 
for Chronic Obstructive Lung Disease stages II–IV) with a re-
cent exacerbation to early (within 2 weeks) or late pulmo-
nary rehabilitation (starting 6 months after randomization 
and in a stable state). The primary outcome was the exacer-
bation rate over 18 months, and secondary outcomes includ-
ed HRQOL and mortality. We used multivariate analyses and 
an intention-to-treat analysis approach.  Results: We ran-
domized 36 patients to pulmonary rehabilitation. On aver-
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There is unequivocal evidence from meta-analyses that 
pulmonary rehabilitation improves symptoms, health-
related quality of life (HRQOL) and exercise capacity 
compared to standard care without rehabilitation  [3] . 
Also, an increasing number of head-to-head trials are in-
forming clinical practice with regard to how to design 
physical exercise programs that are both feasible and ef-
fective for COPD patients  [4, 5] .
 Around the world, the timing of referral of COPD pa-
tients for pulmonary rehabilitation differs from immedi-
ately after exacerbation (early) to later on while the pa-
tient is in a stable state (late)  [2] . Recent evidence suggests 
that pulmonary rehabilitation may be equally if not more 
effective when started immediately after an acute exacer-
bation  [6] . A recently updated Cochrane review identified 
nine randomized trials comparing rehabilitation and 
standard care after a COPD exacerbation. The meta-
analyses showed similar effects of pulmonary rehabilita-
tion after exacerbations on HRQOL [pooled mean differ-
ence in Chronic Respiratory Questionnaire (CRQ) do-
mains between rehabilitation and standard care groups 
of around 0.9] compared to the effects seen in the meta-
analyses of trials that compared rehabilitation and stan-
dard care in stable patients (pooled mean difference 
around 0.9), while the effects on exercise capacity ap-
peared to be greater  [7] . Even more importantly, the meta-
analyses for exacerbations and mortality showed that 
pulmonary rehabilitation after exacerbation led to a large 
reduction in the risk of readmission and mortality as 
compared with standard care.
 Reasons for the effects of such early rehabilitation may 
include the use of a window of opportunity to refer COPD 
patients for rehabilitation when they are receptive to 
changing their health behavior. Moreover, patients expe-
riencing exacerbations often have a number of modifiable 
risk factors for further exacerbations and early death that 
can be addressed effectively by rehabilitation  [8, 9] . How-
ever, it may also just be easier to detect an effect of reha-
bilitation on hospital admissions and death because pa-
tients who have just suffered an exacerbation are at great-
er risk for exacerbations compared to patients in a stable 
state. Potential drawbacks of early rehabilitation include 
the risk of further exacerbations during the rehabilitation 
that may interrupt the program. Also, patients in an un-
stable pulmonary condition usually require more super-
vision compared to patients in a stable state.
 While in some countries most patients are referred for 
(late) pulmonary rehabilitation while in a stable state, in 
other countries patients are traditionally referred for 
(early) pulmonary rehabilitation just after an exacerba-
tion  [2] . There are no head-to-head trials comparing dif-
ferent referral strategies for pulmonary rehabilitation; all 
the trials in the Cochrane review compared early reha-
bilitation to standard care. Our aim was to assess wheth-
er early rehabilitation after an exacerbation is more effec-
tive to reduce exacerbations and to improve HRQOL 
compared with late pulmonary rehabilitation in patients 
with severe COPD at risk for exacerbations.
 Methods 
 Study Design and Patients 
 We conducted a multicenter, randomized controlled trial in 
Switzerland. We randomized COPD patients who were treated for 
an exacerbation to early and late pulmonary rehabilitation using 
an online central randomization system (www.randomizer.at, 
University of Graz) that was accessible to site investigators using 
a password. We used a computerized ‘minimization’ procedure 
that avoids chance baseline imbalances in prognostically impor-
tant variables, which included the modified body mass index, ob-
struction, dyspnea and exercise capacity (BODE) index (1–4 vs. 
5–7 points), in- or outpatient treatment of the acute exacerbation 
before enrolment, the number of hospitalizations in the previous 
year ( ! 2 and  6 2) and whether patients had had respiratory reha-
bilitation in the previous year (yes or no). Using the central ran-
domization and minimization, site investigators could not fore-
see treatment allocation, which ensured concealment of random 
allocation.
 We included patients with COPD, Global Initiative for Chron-
ic Obstructive Lung Disease stages II–IV, who were 40 years or 
older and had just undergone treatment of an acute exacerbation 
in private pulmonary practices and acute care clinics in Switzer-
land. We defined a COPD exacerbation as a sustained worsening 
over days to weeks of the patient’s symptoms from his or her usu-
al stable state that required in- or outpatient medical treatment. 
Patients had to have suffered from at least 2 exacerbations in the 
previous 2 years requiring in- or outpatient care and needed to 
have been diagnosed with COPD during a stable phase within 3 
years before enrolment. The patients needed to be in a medical 
condition that allowed immediate pulmonary rehabilitation or 
recovery at home (see exclusion criteria below). Exclusion criteria 
included hospitalization for other reasons than a COPD exacerba-
tion, long-term noninvasive ventilation (except for continuous 
pressure ventilation for obstructive sleep apnea, which was al-
lowed) and other lung diseases such as doctor-diagnosed asthma. 
We excluded patients who were not eligible for either treatment 
arm because of an impaired level of consciousness, acute confu-
sion, acute changes on the radiograph or electrocardiogram or 
arterial pH  ! 7.35, orthopedic, rheumatologic, cardiovascular or 
neurological disorders that inhibit exercise training, gymnastics 
or guided walking tours, inability to follow patient education in 
German, French or Italian or mental disorders (e.g. substance 
abuse, psychosis, dementia). The protocol was approved by all re-
gional ethics committees. All patients were informed about the 
study both orally and in writing, and they provided written in-
formed consent.
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 Pulmonary Rehabilitation 
 The 12-week pulmonary rehabilitation programs were identi-
cal for both groups and took place in an in- or outpatient reha-
bilitation center with accreditation from the Swiss Society of 
Pneumology following the guidelines of the ‘Working group for 
rehabilitation and patient education’ of the Swiss Society of Pneu-
mology. The decision about the setting of the rehabilitation was 
at the discretion of the physician who treated the patient for his/
her exacerbation but we proposed an algorithm to them that con-
sidered the severity of disease and the severity of the exacerbation. 
For patients who had suffered a severe exacerbation (requiring 
inpatient treatment) and who had a modified BODE score of 5–7, 
the algorithm proposed a 3-week inpatient rehabilitation followed 
by a 9-week outpatient rehabilitation. For patients with a mild to 
moderate exacerbation (requiring outpatient treatment) and a 
modified BODE score of  ! 5, we proposed a 12-week outpatient 
rehabilitation. For patients with other combinations, we did not 
propose in- or outpatient rehabilitation specifically. We recom-
mended rehabilitation with 24 exercise sessions but allowed for a 
range from 18 to 36 exercise sessions considering the diversity of 
the different programs. The exercise sessions included endurance 
and strength training as well as calisthenics, as described previ-
ously  [10] . For patient education, we used the well-established and 
effective ‘Living well with COPD’ program  [11] , which we had 
previously translated into German and Italian; for French speak-
ers we adapted the Canadian French version. The ‘Living well 
with COPD’ program includes several modules in which patients 
learn how to use an individual action plan, how to avoid situations 
and exposures that worsen their symptoms, why and how to use 
their medication and long-term oxygen, how to exercise in the 
home environment and how to adapt their daily planning accord-
ing to their individual abilities. Patients also learned about the 
importance of smoking abstinence and about the development 
and consequences of COPD. We conducted extensive pilot testing 
and training of the patient education material at the study sites 
and considered feedback to improve the material. With the Swiss 
version of the ‘Living well with COPD’ program we also aimed at 
harmonizing the approach to patient education across rehabilita-
tion centers. However, since some programs already had an estab-
lished patient education program, we allowed for a stepwise tran-
sition to the ‘Living well with COPD’ program. Nevertheless, we 
made at least the use of the individual action plan of the ‘Living 
well with COPD’ program a prerequisite for participation in the 
trial.
 Outcome Measures 
 The primary outcome was the rate of exacerbations during 
an 18-month follow-up. We only considered exacerbations that 
required out- or inpatient treatment with systemic corticoste-
roids and/or antibiotics. The secondary outcomes included 
HRQOL as measured by the self-administered standardized 
CRQ  [12, 13] and the Feeling Thermometer  [14] , dyspnea as mea-
sured by the modified Medical Research Council dyspnea scale 
and mortality. All of these outcomes have been validated in the 
languages required here (German, French and Italian) and have 
seen extensive use in clinical research and practice. We per-
formed the follow-up examinations by mail (questionnaires) and 
telephone interviews with patients and primary care physicians 
(exacerbations).
 Sample Size 
 To be eligible for our trial, patients needed to have at least one 
exacerbation per year, as ascertained retrospectively at baseline 
from patient and physician reports. For the duration of the trial, 
we expected a higher number of exacerbations because of the pro-
spective ascertainment of exacerbations by regular interview with 
patients and their general practitioners. Assuming a mean of 3.0 
exacerbations requiring medical (in- or outpatient) treatment per 
patient per year with delayed rehabilitation, we calculated that 118 
patients per group will give 80% power to detect a 20% reduction 
to 2.4 admissions per patient per year by immediate rehabilita-
tion. Assuming a dropout rate of 15%, the total sample size in-
creases to 270. As reported previously, we were not able to recruit 
that number of patients for various reasons  [15] . We introduced 
many strategies to foster recruitment and also conducted a survey 
to learn about barriers for recruitment, all of which has been re-
ported previously.
 Statistical Analysis 
 The main analysis was based on an intention-to-treat ap-
proach but we also repeated and reported the analyses including 
only those patients who finally underwent early or late rehabili-
tation (per-protocol analysis). We first determined the extent of 
missing data, which was  ! 5% for all outcomes and prognostic 
variables used for adjustment. Nevertheless, given the limited 
sample size and in order to avoid selection bias, we used multiple 
imputation using the ‘ice’ command of Stata and generated ten 
data sets. All analyses were based on these data sets using the 
‘micombine’ command of Stata. We compared exacerbation 
rates between treatment groups using a negative binomial re-
gression model rather than a Poisson regression model since 
standard deviations were considerably larger than the mean ex-
acerbation rates, indicating overdispersion. We censored pa-
tients if they died or were lost to follow-up. We performed the 
analyses with and without adjusting for stratification variables. 
In the protocol, we had defined a priori that we would consider 
early and late rehabilitation to be of equivalent effectiveness if 
the difference in mean exacerbation rates was  ! 0.5 exacerba-
tions per person year. For the comparison of secondary out-
comes between randomization and follow-up, we used a gener-
alized estimating equation that accounts for the clustering of 
repeated measurements (0, 3, 6, 12 and 18 months after random-
ization). This regression analysis gives the average difference be-
tween groups over the period of observation. We performed all 
analyses using Stata for Windows (version 10.1, College Station, 
Tex., USA).
 Results 
 We randomized 36 COPD patients to early and late 
pulmonary rehabilitation after an exacerbation. Partici-
pants were elderly patients with a long-standing diag-
nosis of COPD and severely impaired lung function, and 
the majority of patients had been admitted for an exacer-
bation in the 2 years before study enrolment ( table  1 ). 
Three out of 4 patients had a least one comorbidity, and 
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patients randomized to late rehabilitation had a higher 
prevalence of cardiovascular comorbidity. Patient-re-
ported outcomes indicated severely impaired HRQOL 
and high levels of dyspnea, and on average, patients were 
at high risk of death within 3 years ( table 1 ).
 Four patients in each group did not start the pulmo-
nary rehabilitation ( fig.  1 ). In the early rehabilitation 
group, 1 patient died before the beginning of the pulmo-
nary rehabilitation, 1 patient had another exacerbation 
and no longer wanted to participate in a rehabilitation 
program, 1 patient declined rehabilitation after random-
ization because he did not feel to be in a physical condi-
tion for physical exercise and 1 patient could not be con-
tacted anymore by the research team nor the treating 
physician. In the late rehabilitation group, 3 patients no 
longer wanted to follow a rehabilitation program, and for 
1 patient the director of the rehabilitation program con-
sidered the patient to be ineligible for the program for 
unspecified reasons. Overall, 15 (79%) and 13 patients 
(76%) began the early and late rehabilitation, respective-
ly. Five patients with early rehabilitation followed an in-
patient program first, which included physical exercise 
5 times per week for 3 weeks and the patient education 
program. However, 3 of them did not follow a super-
vised outpatient follow-up exercise program and were 
discharged from the inpatient program with a plan for 
home-based exercise. Three patients with early rehabili-
tation had to interrupt or stop the program because of a 
re-exacerbation. Of the late rehabilitation group, 3 pa-
tients nonetheless undertook early rehabilitation; 1 pa-
tient decided to stop his program early and 1 patient par-
ticipating in inpatient rehabilitation did not follow the 
outpatient follow-up program. In each group, 2 patients 
died during the follow-up of 18 months.
 On average, patients with early rehabilitation suffered 
from 2.61 (SD 2.96) exacerbations that required treat-
ment with systemic corticosteroids and/or antibiotics 
over the 18-month period, or 1.93 exacerbations per per-
son year. In the late rehabilitation group, the mean num-
ber of exacerbations per patient was 2.77 (SD 3.41), which 
is 1.89 exacerbations per person year. In the intention-to-
treat approach, the incidence risk ratio for exacerbations 
for the comparison of early versus late rehabilitation was 
0.96 [95% confidence interval (CI) 0.48–1.94; p = 0.91] 
without and 0.83 (95% CI 0.43–1.63; p = 0.60) with adjust-
ment for the modified BODE score, in- or outpatient 
treatment of the acute exacerbation before enrolment, the 
number of hospitalizations and pulmonary rehabilitation 
in the previous year. The per-protocol analysis, which 
only considered patients who underwent early or late re-
habilitation, showed an incidence risk ratio for exacerba-
tions of 0.94 (95% CI 0.52–2.24; p = 0.89) without and 1.07 
(95% CI 0.52–2.24; p = 0.85) with adjustment for stratifi-
cation variables.
Table 1. B aseline characteristics
Early reha-
bilitation
(n = 19)
Late reha-
bilitation
(n = 17)
Demographic characteristics
Age, years 67.589.8 66.586.2
Males 12 (63) 9 (53)
Retired 17 (90) 14 (88)
COPD-specific characteristics
Years since diagnosis 8.084.8 8.084.6
Pack years of smoking 58.6834.8 57.6821.9
Current smokers, n 4821 5829
FEV1 (postbronchodilation)
liters 1.180.4 1.180.3
FEV1 (postbronchodilation) 
% predicted 42.7813.5 46.3815.9
FVC, liters 2.580.9 2.580.6
FEV1/FEV 0.45812.1 0.4680.11
Patients with ≥1 hospital 
admissions in previous 2 years 13 (68) 14 (82)
Patients on systemic 
corticosteroids 5 (26.3) 3 (17.7)
Patients on inhaled corticosteroids 15 (79.0) 17 (100)
Patients on long-acting 
bronchodilators 17 (89.4) 17 (100)
Comorbidities
≥1 comorbidity 14 (74) 14 (82)
Cardiovascular 8 (42) 12 (71)
Endocrine 1 (5) 0
Musculoskeletal 1 (5) 1 (6)
Other 8 (42) 3 (18)
Patient-reported outcomes
CRQ dyspnea 3.6181.78 3.0881.08
CRQ fatigue 3.6481.15 3.5781.18
CRQ emotional function 3.9781.29 3.8581.15
CRQ mastery 4.0481.71 3.8881.35
MRC dyspnea scale 2.2681.24 2.4180.71
Feeling Thermometer 50.4819.3 47.5812.1
Prognostic assessment
ADO index 4.881.8 4.581.0
Risk of 3-year death, % 30.6813.4 27.987.1
Val ues are means 8 SD or numbers (percentages), as appro-
priate. All lung function values refer to measurements during the 
stable state within 3 years before randomization. MRC = Medical 
Research Council; ADO = age, dyspnea and airflow obstruction.
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 Figure 2 and  table 2 show the patient-reported out-
comes over the 18-month follow-up. Dyspnea as mea-
sured by the CRQ improved rapidly in the early reha-
bilitation group and less so in the late rehabilitation 
group. Between months 6 and 12, dyspnea remained sta-
ble in the early rehabilitation group, whereas there was 
a further improvement in the late rehabilitation group. 
Over the entire 18-month period, the average difference 
between the groups was –0.72 (95% CI –1.79 to 0.32; p = 
0.17), favoring the early rehabilitation group although 
not statistically significantly so. We observed a similar 
pattern for the other CRQ domains, although between-
group differences were smaller and only present for 
the first 6 months of follow-up. The Medical Research 
Council dyspnea scale score closely resembles the result 
for the CRQ dyspnea domain, but again the differences 
between groups did not reach statistical significance 
over the entire study period. Only at 6 months did pa-
tients with early rehabilitation have significantly less 
dyspnea. Finally, the Feeling Thermometer showed dif-
Randomized
(n = 36)
Early rehabilitation 
(n = 19)
Late rehabilitation 
(n = 17)
Did not start 
rehabilitation
(n = 4)
Did not start 
rehabilitation
(n = 4)
Followed rehabilitation (n = 15)
• Inpatient + outpatient follow-up     
program (n = 5)
• Outpatient program (n = 10)
Deviations from planned program
• Followed late rehabilitation (n = 0)
• Completed inpatient program but did 
not follow outpatient follow-up  
program (n = 4)
• Had to interrupt program (n = 3)
Followed rehabilitation (n = 13)
• Inpatient + outpatient follow-up     
program (n = 2)
• Outpatient program (n = 11)
Deviations from planned program
• Followed early rehabilitation (n = 3)
• Completed inpatient program but did 
not follow outpatient follow-up  
program (n = 1)
• Had to interrupt program (n = 2)
 Fig. 1. Study flow: 36 COPD patients ran-
domized to early and late pulmonary reha-
bilitation. 
Table 2.  Patient-reported outcomes after 6, 12 and 18 months
Difference between early and late rehabilitation
at 6 months p value at 12 months p value  at 18 months p value
CRQ dyspnea –0.83 (–1.95 to 0.29) 0.14 –0.38 (1.65–0.89) 0.54 –0.51 (–1.77 to 0.74) 0.41
CRQ fatigue –0.44 (–1.26 to 0.39) 0.29 –0.26 (–1.37 to 0.85) 0.64 –0.54 (–1.65 to 0.57) 0.33
CRQ emotional function –0.22 (–1.10 to 0.67) 0.62 0.21 (–0.91 to 1.34) 0.70 –0.50 (–1.51 to 0.51) 0.32
CRQ mastery –0.50 (–1.45 to 0.44) 0.28 0.53 (–0.70 to 1.76) 0.39 –0.27 (–1.13 to 0.59) 0.52
MRC dyspnea scale 0.83 (0.10–1.57) 0.028 0.63 (–0.22 to 1.48) 0.14 0.27 (–0.45 to 1.00) 0.45
Feeling Thermometer –9.68 (–24.70 to 5.34) 0.20 1.40 (–12.00 to 14.79) 0.83 –6.79 (–23.02 to 9.44) 0.40
All comparisons were adjusted for baseline values of the outcome, age and FEV1. Values in parentheses represent 95% CIs. MRC = 
Medical Research Council.
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ferences between groups for the first 6 months, whereas 
the health status of the two groups was similar between 
months 6 and 18.
 Discussion 
 We did not detect an effect of the timing of pulmonary 
rehabilitation on exacerbation rates in patients with se-
vere COPD. Exacerbation rates of patients undergoing 
early and late rehabilitation were similar and well below 
our predefined threshold for a clinically relevant dif-
ference. However, patients with early rehabilitation had 
consistently greater benefits in terms of symptoms and 
HRQOL over the entire 18-month follow-up, although 
the differences compared to patients with late rehabilita-
tion did not reach statistical significance.
 Exacerbations and readmissions are among the most 
relevant problems that need to be addressed to improve 
COPD patient care. Exacerbations have detrimental ef-
fects on the patient’s health status and prognosis and the 
cost implications are enormous  [16–20] . Unfortunately, 
most COPD research focuses on the acute treatment of 
exacerbations or on the long-term management of COPD. 
Unlike for other chronic diseases, there is almost no evi-
dence or ongoing research on the most effective discharge 
and postexacerbation management for COPD patients to 
accelerate recovery from exacerbations and to reduce the 
risk of more exacerbations and admissions. The recent 
Cochrane review on rehabilitation after COPD exacerba-
tions indicated that such a multidisciplinary approach 
that addresses several risk factors for readmissions is ef-
fective to reduce readmissions  [7] .
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 Fig. 2. Patient-reported outcomes over the 18-month follow-up. MRC = Medical Research Council; FT = Feeling Thermometer. 
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 Given the strong evidence for the effectiveness of pul-
monary rehabilitation in stable COPD  [7] and after an 
exacerbation  [7] , we considered it unethical to randomize 
patients to early rehabilitation and standard care (no re-
habilitation). However, we were still interested in observ-
ing the effects of early rehabilitation on recovery from 
exacerbations and for this reason we chose to offer late 
rehabilitation after an arguably long period of 6 months. 
Our trial indicated a trend towards accelerated recovery 
from an exacerbation if patients are referred for early re-
habilitation. Patient-reported outcomes showed higher 
HRQOL for patients with early rehabilitation, and dif-
ferences exceeded the minimal important difference for 
some CRQ domain scores (0.5 units) and the Feeling 
Thermometer (8 units) during the first 6 months, but 
these results did not reach statistical significance. We did 
not observe any difference in exacerbation rates between 
groups, neither from a clinical (difference of  ! 0.5 exacer-
bations per person year as prespecified) nor from a statis-
tical perspective. Finally, we found no indication that ei-
ther the early or late rehabilitation was less safe.
 Our sample size was clearly too small for a definitive 
answer, but the size of our trial was comparable to those 
included in the Cochrane review, where the median num-
ber of patients included in the nine trials was 42. As evi-
dence accumulates, it will become clearer whether the 
timing of referral for pulmonary rehabilitation is critical 
or, if not, whether the most important decision is to refer 
patients with severe COPD at risk for exacerbations for 
pulmonary rehabilitation.
 There are also reasons against early rehabilitation, 
with the most important probably being that patients 
may have to interrupt the rehabilitation because they ex-
perience a re-exacerbation or that they cannot even start 
the rehabilitation program  [2] . In our trial, 3 patients in-
terrupted their early rehabilitation and 4 patients did not 
start it. Also, if an inpatient rehabilitation program is 
available, it is more likely that a patient with severe COPD 
who has suffered from a severe exacerbation will be re-
ferred for inpatient rehabilitation. While patients derive 
great benefit from inpatient rehabilitation, during which 
they are supervised more closely and compliance is better 
than in outpatient programs, the transition back to the 
home environment and to an outpatient follow-up pro-
gram is often difficult. In our trial, 4 out of 7 patients (in 
both groups) who undertook an inpatient program did 
not enroll in an outpatient follow-up program. Thus, al-
though these patients received intense rehabilitation, it 
is probably more difficult to incorporate regular physi-
cal exercise into the patients’ everyday life. On the other 
hand, for patients not referred for early rehabilitation, it 
is often difficult to convince them to undergo rehabilita-
tion once their health state has stabilized again, so that 
the overall proportion of patients enrolling in pulmonary 
rehabilitation might be smaller. 
 We encountered a number of challenges in our trial. 
As reported previously  [15] , recruitment was difficult so 
that we only randomized 15% of the planned sample size. 
As a consequence, the precision for the effect estimates is 
low. Also, the Swiss health care system suffers, as many 
others do, from insufficient links between primary care, 
acute care hospitals and rehabilitation. This is reflected 
by the difficulty of organizing an outpatient follow-up 
program when patients need a transition from the inpa-
tient program to implementation of physical exercise in 
their daily life. It is challenging to ensure continuity of 
care across these settings, which is so important for ef-
fective COPD care. Nevertheless, we believe that the 
strengths of our trial include the delivery of rehabilitation 
programs that are effective if patients follow them, a 
study protocol with attention to methodological details 
to ensure internal validity and finally the multicentric 
nature of our trial.
 In conclusion, early pulmonary rehabilitation of pa-
tients with severe COPD who had suffered from an exac-
erbation did not reduce exacerbation rates compared 
with late rehabilitation. However, our trial indicates that 
postexacerbation management, including pulmonary re-
habilitation, may accelerate the recovery from exacerba-
tions.
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